Riociguat for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)- Responder Analysis of Who Functional Class III Patients from the Patent-1 Study
Abstract
Authors
E. Grünig M. Sikirica J. Curram N. Davie H.A. Ghofrani